This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.
Magnesium malate pairs magnesium with malic acid from the cellular energy cycle, which is why the form is sold for daytime energy. The honest evidence is thin. The main trial, a 1995 pilot in 24 people, showed no clear benefit over placebo in its blinded four week phase at 300 mg magnesium a day, with improvements appearing only in the unblinded six month escalation. Malate is a soluble organic salt, and organic salts have beaten oxide in human comparisons of related forms, though malate itself lacks a direct human absorption trial. Sensible dosing is 100 to 300 mg elemental a day.
Malic acid is a Krebs cycle intermediate, part of the pathway mitochondria use to produce ATP, and magnesium itself is required by the enzymes of that pathway. The energy marketing rests on that biochemistry. Demonstrating that swallowing malate meaningfully changes cellular energy output in people is a different matter, and the human trial evidence has not done so.
Typical supplemental doses are 100 to 300 mg elemental magnesium a day, against UK reference intakes of 300 mg for men and 270 mg for women aged 19 to 64 from all sources. The 1995 pilot used 300 mg magnesium a day with 1,200 mg malic acid in its blinded phase. NHS guidance cautions that more than 400 mg a day from supplements short term commonly causes diarrhoea. Read the elemental figure on the label rather than the compound weight.
Malate is a well soluble organic magnesium salt. In randomised human comparisons of related forms, organic salts and chelates outperformed oxide over 60 days, and it is reasonable to expect malate to behave like its organic siblings, but a direct human absorption trial of magnesium malate specifically has not been published, which most retail descriptions of the form omit. The citrate and bisglycinate entries and the form comparison guides cover the alternatives.
Malate is the form most often taken in the morning or with lunch, partly because the energy framing points that way and partly because people who find glycinate too settling by day prefer to keep glycinate for the evening. With food remains the default. The timing entry covers morning versus night in full.
Oral magnesium at these doses has a wide safety margin in people with normal kidney function, and anyone with reduced kidney function should not supplement without GP advice. Loose stools are the main dose limiting effect. Persistent unexplained fatigue deserves a GP conversation in its own right, since iron status, thyroid function, B12 and sleep all sit upstream of any supplement decision, and the fatigue entries in the iron and B vitamin sections of this library cover those routes.
People with chronic fatigue or fibromyalgia are the group the malate marketing targets, and they are exactly the group for whom the blinded trial evidence is weakest and GP involvement matters most, since both conditions need proper assessment rather than a supplement first approach. Pregnancy has its own magnesium entry on this site.
Magnesium can reduce absorption of tetracycline and quinolone antibiotics and of bisphosphonates taken at the same time, so doses are usually separated by several hours. Long term proton pump inhibitor use and some diuretics lower magnesium. A pharmacist can check spacing against regular prescriptions.
UK reference nutrient intakes are 300 mg a day for men and 270 mg for women aged 19 to 64, with the NHS caution above 400 mg a day supplemental short term. No UK guideline addresses magnesium malate specifically, and no guideline body endorses magnesium for fatigue, which is worth knowing before buying the form for that reason.
A workable order. First, take persistent fatigue to a GP before a supplement shelf, because iron, thyroid, B12 and sleep are the common drivers and each has a proper test. Second, if magnesium is warranted and you want a daytime form, malate is the usual pick, available as magnesium malate at nutritailor.co.uk/products/magnesium-malate. Third, dose at 100 to 300 mg elemental with food in the morning or at lunch. Fourth, judge the result over weeks against something concrete, such as afternoon energy on a simple daily rating, and expect modest effects at best given the state of the evidence.
Claim, magnesium malate is proven for energy and fatigue. The central trial showed no clear benefit over placebo in its blinded phase, with improvements only in the unblinded escalation, which is weak evidence. Claim, malate is the best absorbed form. Organic salts as a family beat oxide in human trials, but malate itself has no direct human absorption trial, so the claim borrows evidence from its siblings. Claim, the malic acid dose in a supplement meaningfully fuels the Krebs cycle. The body synthesises Krebs intermediates continuously, and no human evidence shows supplemental malic acid changes energy output.